文献速递血液透析通路外周动脉疾病

透析通路相关缺血行DRIL时首选手臂静脉作为移植物

Distal revascularization and interval ligation for dialysis access-related ischemia is best performed using arm vein conduit.
PubMed 文献 · J Vasc Surg · 2020-08-31

该回顾性研究纳入2008至2019年因手部缺血行DRIL的66例患者,比较手臂静脉与大腿大隐静脉作为移植物的结局。

要点

  • 使用手臂静脉可避免全身麻醉;有同侧手臂静脉时建议首选。

核心结论

  • DRIL使用手臂静脉优于大隐静脉,症状缓解与通路挽救相似,但伤口并发症明显更少,且可避免全身麻醉。
  • 若存在同侧手臂静脉,应作为DRIL的首选移植物。

研究设计与样本

  • 回顾性研究,从电子病历中识别2008至2019年行DRIL的患者。
  • 共66例因手部缺血行DRIL的患者,手臂静脉组40例,大隐静脉组26例。
  • 采用Wilcoxon秩和、log-rank检验与χ2检验比较两组特征与结局,Kaplan-Meier法评估通路通畅率。

主要发现

  • 两组就诊时缺血分期无差异,多数为3期缺血。
  • 除1例外全部患者症状缓解。

关键数值与推荐

  • 12个月通路通畅率:手臂静脉组86.9%(95%CI 68.3%-94.9%),大隐静脉组93.8%(95%CI 63.2%-99.1%)。
  • 24个月通路通畅率:手臂静脉组82.0%(95%CI 61.3%-92.3%),大隐静脉组76.9%(95%CI 43.0%-92.2%)。

临床怎么用

  • 透析通路相关手部缺血需行DRIL时,应优先评估并使用同侧手臂静脉作为移植物。
  • 选用手臂静脉可配合区域麻醉,减少大隐静脉取材相关伤口并发症。

局限性

  • 为单中心回顾性研究,样本量66例,组间样本量不平衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Distal revascularization and interval ligation (DRIL) is an effective approach to the management of hemodialysis access-related ischemia that offers both symptom relief and access salvage. The great saphenous vein (GSV) has been the most commonly used conduit. However, the use of an ipsilateral arm vein will allow for performance of the operation with the patient under regional anesthesia and might result in lower harvest site morbidity than the GSV. We sought to determine the suitability of DRIL using an arm vein compared with a GSV conduit. METHODS: All patients who had undergone DRIL from 2008 to 2019 were retrospectively identified in the electronic medical records. The characteristics and outcomes of those with an arm vein vs a GSV conduit were compared using the Wilcoxon log-rank and χ2 tests. Access patency was examined using Kaplan-Meier methods, with censoring at lost to follow-up or death. RESULTS: A total of 66 patients who had undergone DRIL for hand ischemia were included in the present study. An arm vein conduit was used in 40 patients (median age, 65 years; 25% male) and a GSV conduit in 26 patients (median age, 58 years; 19% male). No significant differences in comorbidities were found between the two groups, with the exception of diabetes mellitus (arm vein group, 78%; GSV group, 50% GSV; P = .02). No difference in the ischemia stage at presentation was present between the groups, with most patients presenting with stage 3 ischemia. Also, no differences in patency of hemodialysis access after DRIL between the two groups were found (P = .96). At 12 and 24 months after DRIL, 86.9% (95% confidence interval [CI], 68.3%-94.9%) and 82.0% (95% CI, 61.3%-92.3%) of patients with an arm vein conduit had access patency compared with 93.8% (95% CI, 63.2%-99.1%) and 76.9% (95% CI, 43.0%-92.2%) of those with a GSV conduit, respectively. All but one patient had symptom resolution. The incidence of wound complications was significantly greater in the GSV group than in the arm vein group (46% vs 11%; P = .003). DRIL bypass had remained patent in all but one patient in each group, with a median follow-up of 18 months (range, 1-112 months) in the arm vein conduit group and 15 months (range, 0.25-105 months) in the GSV conduit group. CONCLUSIONS: DRIL procedures using an arm vein have advantages over those performed with the GSV. In our series, symptom resolution and access salvage were similar but distinctly fewer wound complications had occurred in the arm vein group. Additionally, the use of an arm vein conduit avoids the need for general anesthesia. If an ipsilateral arm vein is available, it should be the conduit of choice when performing DRIL.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Weaver ML, Holscher CM, Graham A, et al. Distal revascularization and interval ligation for dialysis access-related ischemia is best performed using arm vein conduit. J Vasc Surg. 2020. PMID: 32882351. doi:10.1016/j.jvs.2020.07.105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。